Molecular monitoring of tumour load kinetics predicts disease progression after non-myeloablative allogeneic stem cell transplantation in multiple myeloma.

Raab, M S; Cremer, F W; Breitkreutz, I N; Gerull, S; Luft, T; Benner, A; Goerner, M; Ho, A D; Goldschmidt, H; Moos, M

Raab, M S; Cremer, F W; Breitkreutz, I N; Gerull, S; Luft, T; Benner, A; Goerner, M; Ho, A D; Goldschmidt, H; Moos, M.

Affiliation

Raab MS; Department of Internal Medicine V, University of Heidelberg, Germany. marc.raab@med.uni-heidelberg.de

Ann Oncol ; 16(4): 611-7, 2005 Apr.

Article in En | MEDLINE | ID: mdl-15737985

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Stem Cell Transplantation / Tumor Burden / Multiple Myeloma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2005 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido

Search on Google

Add to My VHL

XML

PubMed Links